Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients

Journal of Infectious Diseases

Volumn 187, Issue 10, 2003, Pages 1639-1645

  Kumar, Deepali ^a,c   Rotstein, Coleman ^b   Miyata, Genevieve ^a   Arlen, Dianne ^b   Humar, Atul ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PNEUMOCOCCUS VACCINE; PREDNISONE;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CONJUGATION; DRUG EFFICACY; ERYTHEMA; FATIGUE; FEMALE; FEVER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ADULT; AGED; ANTIBODIES, BACTERIAL; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE;

EID: 0037569243     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/374784     Document Type: Article

References (24)

1. Fedson DS, Musher DM, Eskola J. Pneumococcal vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed. Philadelphia: WB Saunders, 1998.
2. Linnemann CC Jr, First MR. Risk of pneumococcal infections in renal transplant patients. JAMA 1979; 241:2619-21.
3. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997; 46:1-24.
4. Hausdorff WP, Bryant J, Paradiso PR, et al. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use. I. Clin Infect Dis 2000;30:100-21.
5. Eskola J. Immunogenicity of pneumococcal conjugate vaccines. Pediatr Infect Dis J 2000; 19:388-93.
6. Stein KE. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J Infect Dis 1992; 165(Suppl 1):S49-52.
7. Vernacchio L, Romero-Steiner S, Martinez JE, et al. Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease. J Infect Dis 2000; 181: 1162-6.
8. Chan CY, Molrine DC, George S, et al. Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease. J Infect Dis 1996; 173:256-8.
9. Feikin DR, Elie CM, Goetz MB, et al. Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults. Vaccine 2001; 20:545-53.
10. Quataert SA, Kirch CS, Wiedl LJQ, et al. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89S. Clin Diagn Lab Immunol 1995; 2:590-7.
11. Romero-Steiner S, Libutti D, Pais LB, et al. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin Diagn Lab Immunol 1997;4:415-22.
12. Martinez JE, Romero-Steiner S, Pilishvili T, et al. A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine. Clin Diagn Lab Immunol 1999;6:581-6.
13. Linnemann CC, First MR, Schiffman G. Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine. Arch Intern Med 1986; 146:1554-6.
14. Linnemann CC, First MR, Schiffman G. Response to pneumococcal vaccine in renal transplant and hemodialysis patients. Arch Intern Med 1981; 141:1637-40.
15. Cosio FG, Giebink GS, Le CT, et al. Pneumococcal vaccination in patients with chronic renal disease and renal allograft recipients. Kidney Int 1981; 20:254-8.
16. Silberman HM, Overturf GD, Field RJ, et al. Response of renal allograft recipients to pneumococcal vaccine. Ann Surg 1980; 192:199-201.
17. Kazancolua R, Severa M, Yuksel-Onelc D, et al. Immunization of renal transplant recipients with pneumococcal polysaccharide vaccine. Clin Transplant 2000; 14:61-5.
18. Stark K, Günther M, Schönfeld C, Tullius SG, Bienzle U. Immunisations in solid-organ transplant recipients. Lancet 2002; 359:957-65.
19. Musher DM, Luchi MJ, Watson DA, et al. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis 1990; 161:728-35.
20. Bortolussi R, Marrie TJ, Cunningham J, et al. Serum antibody and opsonic responses after immunization with pneumococcal vaccine in kidney transplant recipients and controls. Infect Immun 1981; 34:20-5.
21. Arnold WC, Steele RW, Rastogi SP, Flanigan WJ. Response to pneumococcal vaccine in renal allograft recipients. Am J Nephrol 1985; 5: 30-4.
22. Johnson SE, Rubin LG, Romero-Steiner S, et al. Correlation of opsonophagocytosis and passive protection assays using human anti-capsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae. J Infect Dis 1999; 180:133-40.
23. Stack AM, Malley R, Thompson CM, et al. Minimum protective serum concentrations of pneumococcal anti-capsular antibodies in infant rats. J Infect Dis 1998; 177: 986-90.
24. Esposito S, Madore DV, Cavagna R, et al. Minimum protective serum concentrations of pneumococcal anti-capsular antibodies in young children. In: Program and abstracts of the 3rd International Symposium on Pneumococcus and Pneumococcal Diseases (Anchorage). Washington, DC: American Society, for Microbiology, 2002.